International experts have warned that the use of investment treaty ‘Investor-State Dispute Settlement (ISDS)’ for attracting foreign investments into Myanmar is risky as it grants the investors the right to initiate dispute settlement proceedings against the government under international laws.
Reflections upon this year’s CND are mixed. On the one hand, some states went further than ever before in openly challenging the current regime on the grounds that, after a century, it needs modernising. That the government of Uruguay is currently considering a domestic policy on cannabis that would put it in breach of the Single Convention shows that, in one instance at least, we have moved beyond rhetoric and posturing.
Drug users in Paris will be able to inject themselves in a secure and monitored environment after a site near the city’s busy Gare du Nord was agreed by the city authorities. The drug consumption room would be open “by the autumn” and, once functioning, will provide free needles to drug users in a sterile environment monitored by healthcare professionals. The project is aimed at reducing the number of people taking drugs in the street, in common areas of apartment buildings and other areas such as car parks.
Law enforcement strategies have utterly failed to even maintain street prices of the key illicit substances. This figure shows that street drug prices fell by roughly a factor of five between in 1980 and 2008. Meanwhile the number of drug offenders locked up in our jails and prisons went from fewer than 42,000 in 1980 to a peak of 562,000 in 2007. We have remarkably little evidence that the billions of dollars spent on supply-side interdiction have much impact.
A set of laws to govern how recreational marijuana should be grown, sold and taxed was signed into law Tuesday in Colorado, where Democratic Gov. John Hickenlooper called the measures the state's best attempt to navigate the uncharted territory of legalized recreational pot. The laws cover how the drug should be raised and packaged, with purchasing limits for out-of-state visitors and a new marijuana driving limit as an analogy to blood alcohol levels. (See also: Highlights of Colorado's new marijuana laws)
"Legal highs" and other new psychoactive synthetic drugs represent a fundamental shift in the market in illicit drug, according to the 2013 annual survey in drug trends by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The EU's drug agency says 73 have become available across Europe, and adds that there is now a firmly established thriving legal highs business with low risks and high profits operating through more than 690 online sites and specialised head shops.
Three United Nations Conventions provide the international legal framework on drug control, instructing countries to limit drug supply and use to medical and scientific purposes. Yet, debate continues on the decriminalisation, or even legalisation, of drugs, particularly cannabis. Models under development for the legal supply of cannabis are described in this analysis, as well as some of the questions they raise.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
Following the release of a major draft report on drug policy in the Americas, the secretary-general of the Organisation of American States (OAS) called for the beginning of debate aimed at reforming those policies throughout the region. Many of the region’s leaders have expressed frustration with the limits and exorbitant costs of current policies and their desire for a more creative debate. But according to John Walsh, who participated in writing the OAS report, there is a lot of scepticism over whether the OAS will be up to the task, especially given U.S. domination of the issue.
Seven of the world’s eight most violent countries lie on the bloody trafficking route from the cocaine fields of the Andes to the nostrils of North America. So it is unsurprising that Latin American leaders are fed up with the way drugs are policed. The international rules on prohibition were laid down by the United Nations more than 50 years ago, making drug policy difficult for individual countries to reform. But diplomats and do-gooders are finding ever more chinks in prohibition’s legal armour.
The laws regarding cannabis possession in Germany are nothing if not confusing. It is illegal to possess or consume marijuana. Except that carrying a small amount for personal use has no criminal repercussions. But how much is okay? That depends on where you are. Each state has a different rule. In Berlin, you can carry 15 grams of marijuana. In Munich? Just six.
The personal use of illegal drugs, including heroin and crack cocaine, should be decriminalized as part of a federal-provincial strategy to tackle drug abuse, the Canadian Drug Policy Coalition argues. Their report, Getting To Tomorrow, denounces the Harper government’s aggressive war on drugs, which puts the emphasis on law enforcement while steering money away from harm-reduction initiatives like Vancouver’s supervised injection site. (See also: Call to legalize 'hard' drugs meets opposition)
Two-thirds of the country's 650 cannabis cafes continue to sell marijuana to tourists, despite the ban implemented at the beginning of this year. In total 111 cafes in 33 cities - including Amsterdam, Rotterdam, Utrecht and The Hague - took part in the survey, set up by Epicurus, a foundation launched by coffee shop owners. The survey shows there is a sharp north-south divide. (See also: Deal struck in Maastricht that could let tourists back into cannabis cafes)
The largest study to date confirms that ketamine — a “club drug” that is also legally used as an anesthetic — could be a quick and effective way to relieve depression. The results were presented at the annual meeting of the American Psychiatric Association and represent growing excitement about ketamine’s potential. The study included 72 patients who had previously failed to respond to at least two other medications.